* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
STC:DBD's PEG Ratio is ranked better than 53.47% of 346
companies
in the Drug Manufacturers industry
Industry Median: 1.715
vs STC:DBD: 1.52
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Binh Dinh Pharmaceutical And Medical Equipment JSC PEG Ratio Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC PEG Ratio Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC PEG Ratio vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a PEG Ratio of 1.52 as of Jun. 29, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is 39% above median its historical median of 1.09. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's PEG Ratio has ranged from 0.85 to 1.89. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #161 out of 346 companies in the Drug Manufacturers industry, placing it in the top 46.5%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's PEG Ratio too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current PEG Ratio of 1.52 is 39% above median its 10-year median of 1.09. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 1.89. The Drug Manufacturers industry median PEG Ratio is 1.72. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 1.52 is 11.4% below this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #161 out of 346 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #161 out of 346 companies for PEG Ratio. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median PEG Ratio is 1.72. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 1.52 is 11.4% below this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own PEG Ratio has ranged from 0.85 to 1.89 over the past decade. While the company's 10-year median is 1.09 vs. the industry median of 1.72, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.72, based on 346 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current PEG Ratio of 1.52 is 11.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current PEG Ratio is 1.52, which is 39% above median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,212.47, compared to a current price of ₫53,200.00 — trading 1.9% above its estimated fair value. The current PEG Ratio is 1.52, which is 39% above median its 10-year median of 1.09 and 11.4% below the Drug Manufacturers industry median of 1.72. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current PEG Ratio is 1.52 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued.
The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
PEG Ratio: 1.52 (39% above median its 10-year median of 1.09)
GF Value™: ₫52,212.47 vs. price of ₫53,200.00 (1.9% above fair value)
Industry Position: 11.4% below the Drug Manufacturers median (#161 of 346)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
